MAD2L1 and gastric cancer: As a pro-oncogene upregulated in gastric cancer, MAD2L1 (mitotic arrest deficient 2-like protein 1) can be downregulated expression by miR-30a-3p, resulting in inhibition of the proliferation of gastric cancer cells (Wang et al., 2019).